Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
Objective: This study aims to explore the risk signals of osteonecrosis of the jaw induced by antiresorptive drugs and provide references for the clinical safety application.Method: According to the FDA's Adverse Event Reporting System (FAERS), from January 2004 to September 2021, we chose &quo...
Saved in:
Main Authors: | Jing Peng (Author), Hui Wang (Author), Zhen Liu (Author), Zhen-Liang Xu (Author), Mei-Xia Wang (Author), Qi-Miao Chen (Author), Ming-Li Wu (Author), Xiao-Lei Ren (Author), Qiu-Hua Liang (Author), Fu-Peng Liu (Author), Bo Ban (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024) -
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
by: Akira Baba, et al.
Published: (2019) -
Knowledge and clinical behavior on antiresorptive medications and osteonecrosis of the jaws: a cross-sectional study
by: Daniel Amaral Alves MARLIÉRE, et al.
Published: (2019) -
Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database
by: Inada A, et al.
Published: (2018) -
Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
by: Masanori Nashi, et al.
Published: (2023)